Pricing Log in Create free account

Azora Therapeutics, Inc. (AZR) vs IN8bio, Inc. (INAB)

Azora Therapeutics, Inc. and IN8bio, Inc. are both Biotechnology companies. Azora Therapeutics, Inc. and IN8bio, Inc. are of similar size ($9.9M and $9.7M). Across the 8 metrics below, Azora Therapeutics, Inc. leads on 5 and IN8bio, Inc. on 3.

Valuation

Metric AZR INAB Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B n/m 1.20 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 0.21 n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (471.30%) (176.53%) (32.28%)
Free cash flow yield (67.90%) (88.73%) (22.27%)

Profitability

Metric AZR INAB Biotechnology median
Gross margin 0.00% 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 352.60% (141.83%) (50.30%)
Return on assets (322.10%) (109.44%) (45.47%)
Return on invested capital 0.00% (6,204.91%) 0.00%

Growth

Metric AZR INAB Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 82.46% 74.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AZR INAB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 5.78 4.74
Net debt to EBITDA 0.75 1.56 1.01

Dividend

Metric AZR INAB Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric AZR INAB Biotechnology median
Market cap 9.88m 9.73m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack